| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | L-685458 | CCLE | pan-cancer | AAC | 0.053 | 0.3 |
| mRNA | OSU-03012 | GDSC1000 | pan-cancer | AAC | -0.038 | 0.3 |
| mRNA | ML050 | CTRPv2 | pan-cancer | AAC | 0.041 | 0.3 |
| mRNA | SCH-529074 | CTRPv2 | pan-cancer | AAC | 0.042 | 0.3 |
| mRNA | SKI-II | CTRPv2 | pan-cancer | AAC | 0.04 | 0.3 |
| mRNA | decitabine:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.034 | 0.3 |
| mRNA | ML210 | CTRPv2 | pan-cancer | AAC | -0.036 | 0.3 |
| mRNA | dabrafenib | CTRPv2 | pan-cancer | AAC | -0.055 | 0.3 |
| mRNA | valdecoxib | CTRPv2 | pan-cancer | AAC | 0.039 | 0.3 |
| mRNA | Camptothecin | GDSC1000 | pan-cancer | AAC | -0.038 | 0.3 |